Results
|
|
101.
|
Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivo. [electronic resource] by
- Sparreboom, A
- Verweij, J
- van der Burg, M E
- Loos, W J
- Brouwer, E
- Viganò, L
- Locatelli, A
- de Vos, A I
- Nooter, K
- Stoter, G
- Gianni, L
Producer: 19981022
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 4
Availability: No items available.
|
|
|
102.
|
Differential modulation of cisplatin accumulation in leukocytes and tumor cell lines by the paclitaxel vehicle Cremophor EL. [electronic resource] by
- de Vos, A I
- Nooter, K
- Verweij, J
- Loos, W J
- Brouwer, E
- de Bruijn, P
- Ruijgrok, E J
- van der Burg, M E
- Stoter, G
- Sparreboom, A
Producer: 19980202
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 8
Availability: No items available.
|
|
|
103.
|
Disposition of docetaxel in the presence of P-glycoprotein inhibition by intravenous administration of R101933. [electronic resource] by
- van Zuylen, L
- Sparreboom, A
- van der Gaast, A
- Nooter, K
- Eskens, F A L M
- Brouwer, E
- Bol, C J
- de Vries, R
- Palmer, P A
- Verweij, J
Producer: 20020718
In:
European journal of cancer (Oxford, England : 1990) vol. 38
Availability: No items available.
|
|
|
104.
|
Pharmacokinetic, metabolic, and pharmacodynamic profiles in a dose-escalating study of irinotecan and cisplatin. [electronic resource] by
- de Jonge, M J
- Verweij, J
- de Bruijn, P
- Brouwer, E
- Mathijssen, R H
- van Alphen, R J
- de Boer-Dennert, M M
- Vernillet, L
- Jacques, C
- Sparreboom, A
Producer: 20000217
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 18
Availability: No items available.
|
|
|
105.
|
Hypoxia inducible factor-1-alpha (HIF-1alpha) is related to both angiogenesis and inflammation in rheumatoid arthritis. [electronic resource] by
- Brouwer, E
- Gouw, A S H
- Posthumus, M D
- van Leeuwen, M A
- Boerboom, A L
- Bijzet, J
- Bos, R
- Limburg, P C
- Kallenberg, C G M
- Westra, J
Producer: 20100331
In:
Clinical and experimental rheumatology vol. 27
Availability: No items available.
|
|
|
106.
|
Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study). [electronic resource] by
- Meiners, P M
- Vissink, A
- Kroese, F G M
- Spijkervet, F K L
- Smitt-Kamminga, N Sillevis
- Abdulahad, W H
- Bulthuis-Kuiper, J
- Brouwer, E
- Arends, S
- Bootsma, H
Producer: 20140818
In:
Annals of the rheumatic diseases vol. 73
Availability: No items available.
|
|
|
107.
|
Phase I and pharmacological study of increased dose oral topotecan in combination with intravenous cisplatin. [electronic resource] by
- Gelderblom, A J
- Loos, W J
- de Jonge, M J
- Sparreboom, A
- Planting, A S
- van der Burg, M E
- Brouwer, E
- Verheij, C
- Ouwens, L
- Hearn, S
- Verweij, J
Producer: 20010215
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 11
Availability: No items available.
|
|
|
108.
|
Drug-administration sequence does not change pharmacodynamics and kinetics of irinotecan and cisplatin. [electronic resource] by
- de Jonge, M J
- Verweij, J
- Planting, A S
- van der Burg, M E
- Stoter, G
- de Boer-Dennert, M M
- de Bruijn, P
- Brouwer, E
- Vernillet, L
- Sparreboom, A
Producer: 19991027
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 5
Availability: No items available.
|
|
|
109.
|
Health effects of pesticides in the flower-bulb culture in Holland. [electronic resource] by
- Verberk, M M
- Brouwer, D H
- Brouwer, E J
- Bruyzeel, D P
- Emmen, H H
- Van Hemmen, J J
- Hooisma, J
- Jonkman, E J
- Ruijten, M W
- Sallé, H J
Producer: 19910823
In:
La Medicina del lavoro vol. 81
Availability: No items available.
|
|
|
110.
|
Elastase, but not proteinase 3 (PR3), induces proteinuria associated with loss of glomerular basement membrane heparan sulphate after in vivo renal perfusion in rats. [electronic resource] by
- Heeringa, P
- Van den Born, J
- Brouwer, E
- Dolman, K M
- Klok, P A
- Huitema, M G
- Limburg, P C
- Bakker, M A
- Berden, J H
- Daha, M R
- Kallenberg, C G
Producer: 19960910
In:
Clinical and experimental immunology vol. 105
Availability: No items available.
|
|
|
111.
|
Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients. [electronic resource] by
- Brouwer, E
- Havenga, M J
- Ophorst, O
- de Leeuw, B
- Gijsbers, L
- Gillissen, G
- Hoeben, R C
- ter Horst, M
- Nanda, D
- Dirven, C
- Avezaat, C J
- Goudsmit, J
- Sillevis Smitt, P
Producer: 20070320
In:
Cancer gene therapy vol. 14
Availability: No items available.
|
|
|
112.
|
|
|
|
113.
|
Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation. [electronic resource] by
- de Vries, M K
- Brouwer, E
- van der Horst-Bruinsma, I E
- Spoorenberg, A
- van Denderen, J C
- Jamnitski, A
- Nurmohamed, M T
- Dijkmans, B A C
- Aarden, L A
- Wolbink, G J
Producer: 20091117
In:
Annals of the rheumatic diseases vol. 68
Availability: No items available.
|
|
|
114.
|
The formation of autoantibodies and antibodies to TNF-α blocking agents in relation to clinical response in patients with ankylosing spondylitis. [electronic resource] by
- Arends, S
- Lebbink, H R
- Spoorenberg, A
- Bungener, L B
- Roozendaal, C
- van der Veer, E
- Houtman, P M
- Griep, E N
- Limburg, P C
- Kallenberg, C G M
- Wolbink, G J
- Brouwer, E
Producer: 20101214
In:
Clinical and experimental rheumatology vol. 28
Availability: No items available.
|
|
|
115.
|
Phase I pharmacologic study of oral topotecan and intravenous cisplatin: sequence-dependent hematologic side effects. [electronic resource] by
- de Jonge, M J
- Loos, W J
- Gelderblom, H
- Planting, A S
- van der Burg, M E
- Sparreboom, A
- Brouwer, E
- van Beurden, V
- Mantel, M A
- Doyle, E
- Hearn, S
- Ross, G
- Verweij, J
Producer: 20000615
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 18
Availability: No items available.
|
|
|
116.
|
Adaptive intrapatient dose escalation of cisplatin in combination with low-dose vp16 in patients with nonsmall cell lung cancer. [electronic resource] by
- Schellens, J H M
- Planting, A S T
- van Zandwijk, N
- Ma, J
- Maliepaard, M
- van der Burg, M E L
- de Boer-Dennert, M
- Brouwer, E
- van der Gaast, A
- van den Bent, M J
- Verweij, J
Producer: 20030505
In:
British journal of cancer vol. 88
Availability: No items available.
|
|
|
117.
|
Large-vessel vasculitis: interobserver agreement and diagnostic accuracy of 18F-FDG-PET/CT. [electronic resource] by
- Lensen, K D F
- Comans, E F I
- Voskuyl, A E
- van der Laken, C J
- Brouwer, E
- Zwijnenburg, A T
- Pereira Arias-Bouda, L M
- Glaudemans, A W J M
- Slart, R H J A
- Smulders, Y M
Producer: 20151116
In:
BioMed research international vol. 2015
Availability: No items available.
|
|
|
118.
|
Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study. [electronic resource] by
- Boumans, M J H
- Houbiers, J G A
- Verschueren, P
- Ishikura, H
- Westhovens, R
- Brouwer, E
- Rojkovich, B
- Kelly, S
- den Adel, M
- Isaacs, J
- Jacobs, H
- Gomez-Reino, J
- Holtkamp, G M
- Hastings, A
- Gerlag, D M
- Tak, P P
Producer: 20120221
In:
Annals of the rheumatic diseases vol. 71
Availability: No items available.
|
|
|
119.
|
Association of genetic variants in the IL4 and IL4R genes with the severity of joint damage in rheumatoid arthritis: a study in seven cohorts. [electronic resource] by
- Krabben, A
- Wilson, A G
- de Rooy, D P C
- Zhernakova, A
- Brouwer, E
- Lindqvist, E
- Saxne, T
- Stoeken, G
- van Nies, J A B
- Knevel, R
- Huizinga, T W J
- Toes, R
- Gregersen, P K
- van der Helm-van Mil, A H M
Producer: 20140127
In:
Arthritis and rheumatism vol. 65
Availability: No items available.
|
|
|
120.
|
Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritis. [electronic resource] by
- Martens, H A
- Nienhuis, H L A
- Gross, S
- van der Steege, G
- Brouwer, E
- Berden, J H M
- de Sévaux, R G L
- Derksen, R H W M
- Voskuyl, A E
- Berger, S P
- Navis, G J
- Nolte, I M
- Kallenberg, C G M
- Bijl, M
Producer: 20121116
In:
Lupus vol. 21
Availability: No items available.
|